The Anova Health Institute is proud to announce that it has received a five-year PEPFAR grant through USAID’s APACE activity (Accelerating Program Achievements to Control the Epidemic). This work will contribute to HIV epidemic control in South Africa and empower Anova to rapidly scale-up programs that alleviate the burden of HIV and TB.
Anova launched this ambitious, achievable and target-driven program on the 1st of October 2018, aligning with PEPFAR’s aim to support South Africa’s National Strategic Plan for HIV and TB and the UNAIDS 90-90-90 goals to end AIDS. The ANOVAAPACE Program aims to accelerate and sustain epidemic control in the target districts through a data-driven, people-centred and evidence-informed approach.
The ANOVAAPACE Program will work in partnership with the Departments of Health in the City of Johannesburg and Sedibeng in Gauteng, and Mopani and Capricorn districts in Limpopo. Anova is already a trusted partner of the Department of Health (DoH), strengthening health systems through direct service delivery and technical assistance. Anova’s innovative response has enabled increased access to quality services.
By rolling out this collaborative effort, the program will contribute to South Africa’s vision of an additional two million people being started on HIV treatment by 2020. The ANOVAAPACE Program will identify over 400 000 people living with HIV, who are HIV-positive and not in care, through HIV testing services and community mobilisation and initiate them on antiretroviral treatment.